[Growth regulatory mechanisms of recombinant human interleukin-6 on human lung carcinoma cell lines]

Zhonghua Yi Xue Za Zhi. 1997 Mar;77(3):194-6.
[Article in Chinese]

Abstract

Objectives: To detect the activity of interleukin-6 (rhIL-6) on human lung cancer and the influences of recombinant human IL-6 (rhIL-6) on the in vitro growth of high-metastatic human lung giant cell carcinoma cell line PG and low-metastatic human lung adenocarcinoma cell line PAa.

Methods: The effects of rhIL-6 on the expressions of IL-6, IL-6R, c-myc, c-fos and c-jun mRNAs were analyzed by Northern blotting hybridization.

Results: rhIL-6 could stimulate the in vitro growth of both PG and PAa cells, in a dose-and-time-dependent manner. Both PG and PAa cells were shown to express IL-6 and IL-6R identified by reverse transcription PCR analysis. Northern blotting hybridization revealed that rhIL-6 up-regulated mRNA levels of IL-6, IL-6R and c-myc rather than those of c-fos and c-jun.

Conclusion: These data suggest that rhIL-6 may promote the proliferation of human lung cancer cell lines PG and PAa, which might, at least partly, be related to the up-regulation of expressions of IL-6, IL-6R, c-myc gene transcript.

Publication types

  • English Abstract

MeSH terms

  • Adenocarcinoma / pathology*
  • Carcinoma, Giant Cell / pathology*
  • Cell Division / drug effects
  • Gene Expression Regulation, Neoplastic / drug effects
  • Genes, myc
  • Humans
  • Interleukin-6 / pharmacology*
  • Lung Neoplasms / pathology*
  • Proto-Oncogene Proteins c-myc / biosynthesis
  • Recombinant Proteins / pharmacology
  • Tumor Cells, Cultured / drug effects

Substances

  • Interleukin-6
  • Proto-Oncogene Proteins c-myc
  • Recombinant Proteins